ClinVar Miner

Submissions for variant NM_000208.4(INSR):c.2275C>T (p.Arg759Trp) (rs752552480)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000484795 SCV000566021 likely pathogenic not provided 2015-03-31 criteria provided, single submitter clinical testing The R759W substitution in the INSR gene has not been published as a pathogenic variant, nor has it been reported as abenign polymorphism to our knowledge. The R759W variant was not observed in approximately 6,500individuals of European and African American ancestry in the NHLBI Exome Sequencing Project,indicating it is not a common benign variant in these populations. The R759W variant is a non-conservativeamino acid substitution which is likely to impact secondary protein structure, as these residues differ inpolarity, charge, size and/or other properties. This substitution occurs at a position that is conserved acrossspecies. In silico analyses predict that this variant is probably damaging to the protein structure/function. Amissense variant in a nearby residue (R762S) has been reported in association with insulin-resistantdiabetes (Yoshimasa et al., 1988), supporting the functional importance of this region of the protein. TheR759W variant is a strong candidate for a pathogenic variant; however, the possibility that it may bea rare benign variant cannot be excluded.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.